USU specialists conduct diagnostic tests to detect antibodies to the SARS-CoV-2 virus
In June, the Research Medical and Biological Center of USU is going to launch a diagnostic study to
detect antibodies to SARS-CoV-2, class M (Ig M) and G (Ig G) antibodies, using
enzyme-linked immunosorbent assay.
What is the purpose of donating blood for
antibodies to SARS-CoV-2?
If you did not suffer from this infectious disease, the presence of blurred and asymptomatic clinical forms is not excluded, in which an immune response is formed and antibodies to SARS-CoV-2 are detected in the blood.
If you have suffered an infection caused by SARS-CoV-2 - find out if you have developed immunity to this infection.
If you have risk factors for SARS-CoV-2 infection or have been in contact with a person with SARS-CoV-2 - early diagnosis - IgM detection for SARS-CoV-2.
The study includes the simultaneous determination of the parameters of the immune response to contact with coronavirus: the presence of antibodies of various classes to antigens of the causative agent COVID-19 in human serum (plasma).
Specific IgM (early antibodies) in case of COVID-19 appear on the 5-6th day after the disease, and in some cases at the end of the incubation period. IgG to SARS-CoV-2 (later antibodies) is identified in patients from the 10-12th day of the infection process.
The USU team wishes everyone good health and safety precautions! Take care of yourself and others.